The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study).
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2015
At a glance
- Drugs Cilostazol (Primary)
- Indications Peripheral arterial disorders; Stroke
- Focus Therapeutic Use
- Acronyms SPAD
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2012 Additional lead trial centers identified as reported by ClinicalTrials.gov.
- 15 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.